151 related articles for article (PubMed ID: 6376145)
1. Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients.
Scheen AJ; Lefebvre PJ; Luyckx AS
Eur J Clin Pharmacol; 1984; 26(4):471-4. PubMed ID: 6376145
[TBL] [Abstract][Full Text] [Related]
2. Effect of sulfonylurea on glucose, insulin and C-peptide responses to a meal stimulus in a patient with type 2 diabetes and liver disease.
Ahrén B; Scherstén B
Acta Med Scand; 1984; 215(5):487-91. PubMed ID: 6430037
[TBL] [Abstract][Full Text] [Related]
3. Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
Ahrén B; Lundquist I; Scherstén B
Diabetes Res; 1986 Jul; 3(6):293-300. PubMed ID: 3530592
[TBL] [Abstract][Full Text] [Related]
4. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
[TBL] [Abstract][Full Text] [Related]
5. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M
Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723
[TBL] [Abstract][Full Text] [Related]
6. Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study.
Groop LC; Ratheiser K; Luzi L; Melander A; Simonson DC; Petrides A; Bonadonna RC; Widén E; DeFronzo RA
Acta Diabetol; 1991; 28(2):162-8. PubMed ID: 1777653
[TBL] [Abstract][Full Text] [Related]
7. Influence of sulfonylureas on the secretion, disposal and effect of insulin.
Almér LO; Johansson E; Melander A; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 22(1):27-32. PubMed ID: 7047169
[TBL] [Abstract][Full Text] [Related]
8. The acute effect of preprandial exogenous and endogenous sulphonylurea-stimulated insulin secretion on postprandial glucose excursions in patients with type 2 diabetes.
Groop PH; Melander A; Groop LC
Diabet Med; 1993; 10(7):633-7. PubMed ID: 8403824
[TBL] [Abstract][Full Text] [Related]
9. Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide.
Almér LO; Johansson E; Melander A; Wåhlin-Boll E
Acta Med Scand Suppl; 1981; 656():11-8. PubMed ID: 7046346
[TBL] [Abstract][Full Text] [Related]
10. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
Simpson HC; Sturley R; Stirling CA; Reckless JP
Diabet Med; 1990 Feb; 7(2):143-7. PubMed ID: 2137755
[TBL] [Abstract][Full Text] [Related]
11. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic equivalence of once- and thrice-daily glipizide.
Wåhlin-Boll E; Groop L; Karhumaa S; Groop PH; Tötterman KJ; Melander A
Eur J Clin Pharmacol; 1986; 31(1):95-9. PubMed ID: 3536529
[TBL] [Abstract][Full Text] [Related]
13. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
[TBL] [Abstract][Full Text] [Related]
14. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
Carroll MF; Gutierrez A; Castro M; Tsewang D; Schade DS
J Clin Endocrinol Metab; 2003 Nov; 88(11):5248-54. PubMed ID: 14602757
[TBL] [Abstract][Full Text] [Related]
15. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects.
Wåhlin-Boll E; Melander A; Sartor G; Scherstén B
Eur J Clin Pharmacol; 1980 Oct; 18(3):279-83. PubMed ID: 7002565
[TBL] [Abstract][Full Text] [Related]
16. Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion.
Sartor G; Ursing D; Nilsson-Ehle P; Wåhlin-Boll E; Melander A
Eur J Clin Pharmacol; 1987; 33(3):279-82. PubMed ID: 3319648
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus.
Bitzén PO; Melander A; Scherstén B; Svensson M; Wåhlin-Boll E
Eur J Clin Pharmacol; 1992; 42(1):77-83. PubMed ID: 1541320
[TBL] [Abstract][Full Text] [Related]
18. The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.
Bitzén PO; Melander A; Scherstén B; Wåhlin-Boll E
Eur J Clin Pharmacol; 1988; 35(1):31-7. PubMed ID: 3065086
[TBL] [Abstract][Full Text] [Related]
19. The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.
Mooradian AD; Albert SG; Bernbaum M; Plummer S
Diabetes Care; 1996 Aug; 19(8):883-4. PubMed ID: 8842609
[TBL] [Abstract][Full Text] [Related]
20. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
Levy J; Vandenberg M; Grunberger G
Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
